Congenital Cardiovascular ShuntSymptoms, Doctors, Treatments, Advances & More
Learn About Congenital Cardiovascular Shunt
Pediatric Cardiology In Lawrenceville
Bryan H. Goldstein MD, FACC, FSCAI is a pediatric interventional cardiologist and is certified in pediatric cardiology by the American Board of Pediatrics. He is director of the cardiac catheterization laboratory and interventional cardiology service at UPMC Children’s Hospital of Pittsburgh and is a Professor of Pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from Boston University School of Medicine and completed his residency at the Boston Combined Residency in Pediatrics (Children’s Hospital Boston) and fellowship at C.S. Mott Children’s Hospital (University of Michigan Medicine).Dr. Goldstein joined the UPMC Heart and Vascular Institute in 2019. His clinical interests include congenital cardiac catheterization, minimally invasive transcatheter therapies, and single ventricle (Fontan) circulation. Dr. Goldstein has published numerous scientific articles in peer-reviewed journals, is a frequent faculty member and presenter at national and international meetings, and is a member of Alpha Omega Alpha Honor Medical Society, American Academy of Pediatrics (FAAP), American Heart Association, American College of Cardiology (FACC) and Society for Cardiovascular Angiography & Interventions (FSCAI). He is vice president of the Congenital Cardiac Research Collaborative (CCRC).View Dr. Goldstein's full list of publications from PubMed. Dr. Goldstein is rated as an Elite provider by MediFind in the treatment of Congenital Cardiovascular Shunt. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Congenital Cardiovascular Shunt, Tetralogy of Fallot, Pulmonary Atresia, Stent Placement, and Angioplasty. Dr. Goldstein is board certified in American Board Of Pediatrics. Dr. Goldstein is currently accepting new patients.
Swedish Cerebrovascular Center
Dr. Monteith's philosophy of care is to approach the care of each of his patients as if they were a member of his own family. He strives to give his patients the best possible outcome by combining the latest technological advances with personalized clinical care. When possible, he uses endovascular or minimally invasive surgical approaches, so that his patients can recover from their procedure and get back to their normal lives as soon as possible. Dr. Monteith is rated as a Distinguished provider by MediFind in the treatment of Congenital Cardiovascular Shunt. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Congenital Cardiovascular Shunt, Normal Pressure Hydrocephalus, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery. Dr. Monteith is board certified in American Board Of Neurological Surgery. Dr. Monteith is currently accepting new patients.
St. Louis Children's Hospital
Andrew Glatz is a Pediatric Cardiologist practicing medicine in Saint Louis, Missouri. Dr. Glatz is rated as an Elite provider by MediFind in the treatment of Congenital Cardiovascular Shunt. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pulmonary Atresia with Intact Ventricular Septum, Pulmonary Atresia, Tetralogy of Fallot, Stent Placement, and Angioplasty.
Summary: Patent Foramen Ovale (PFO) is a common congenital heart defect. Recent studies have suggested a potential association between PFO and migraines, particularly migraine with aura. It is hypothesized that PFO may allow microemboli or vasoactive substances from venous blood to bypass pulmonary metabolism and enter the arterial system directly, potentially triggering migraines. Although PFO closure has...
Summary: Sinus venosus defect (SVD) accounts for 10% of atrial septal defects and is characterized by an anomalous pulmonary venous return in the superior vena cava associated with a high situated atrial septal defect. Since 2013, transcatheter correction of this congenital heart disease has emerged as a new treatment option. The procedure involves placement of a covered stent in the superior vena cava tha...